Long-Term Assessment of Pelvic Organ Prolapse Reoperation Risk in Obese Women: Vaginal and Laparoscopic Approaches.
POP repair
complications
long-term outcomes
obesity
pelvic organ prolapse
recurrence
reoperation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Nov 2022
21 Nov 2022
Historique:
received:
02
10
2022
revised:
08
11
2022
accepted:
17
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
27
11
2022
Statut:
epublish
Résumé
The aim of this study was to compare reoperation risks after pelvic organ prolapse repair at 5-year follow-up between obese, overweight, and normal-weight women and to assess these risks accounting for the surgical procedure. We performed a retrospective chart review of all the women who underwent POP repair by transvaginal mesh surgery between January 2005 and January 2009 or laparoscopic sacrocolpopexy between January 2003 and December 2013 at the Gynecologic Surgery Department of the Lille University Hospital. During the study period, 744 women who underwent POP repair were divided into three groups: 382 (51%), 240 (32%), and 122 (16%) in the nonobese group (BMI < 25 kg/m²), overweight group (25 kg/m² ≤ BMI < 30 kg/m²), and obese group (BMI ≥ 30 kg/m²), respectively. The primary outcome was global reoperation. The median duration of follow-up was 87 months. The risks of global reoperation did not significantly differ between the three BMI groups (adjusted HR (95% CI): 1.12 (0.69 to 1.82) for overweight women and 0.90 (0.46 to 1.74) for obese women compared to normal-weight women, adjusted p = 0.80), nor among the women who underwent transvaginal mesh surgery or laparoscopic sacrocolpopexy. The risks of reoperation for POP recurrence, stress urinary incontinence, or mesh-related complications did not significantly differ between the three BMI groups in the overall population nor accounting for the surgical procedure. In conclusion, obesity does not seem to be a risk factor of reoperation for POP recurrence, SUI, or mesh-related complications in the long term regardless of the surgical approach.
Identifiants
pubmed: 36431343
pii: jcm11226867
doi: 10.3390/jcm11226867
pmc: PMC9695500
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Obstet Gynecol. 2008 Dec;199(6):690.e1-8
pubmed: 18845288
Eur Urol. 2018 Aug;74(2):167-176
pubmed: 29472143
Prog Urol. 2014 Dec;24(17):1106-13
pubmed: 25450756
Am J Obstet Gynecol. 2010 May;202(5):503.e1-4
pubmed: 20171604
Int Urogynecol J. 2015 Nov;26(11):1559-73
pubmed: 25966804
Int Urogynecol J. 2017 Feb;28(2):231-239
pubmed: 27549223
Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38
pubmed: 24222017
Am J Obstet Gynecol. 2016 Nov;215(5):601.e1-601.e4
pubmed: 27342042
Int J Gynaecol Obstet. 2010 Mar;108(3):244-6
pubmed: 20022004
Am J Obstet Gynecol. 2022 Aug;227(2):306.e1-306.e16
pubmed: 35654112
Am J Obstet Gynecol. 2019 Nov;221(5):410-428.e19
pubmed: 31082383
JAMA. 2012 Feb 1;307(5):491-7
pubmed: 22253363
Am J Obstet Gynecol. 2007 Jul;197(1):98.e1-8
pubmed: 17618776
Am J Obstet Gynecol. 2003 Nov;189(5):1261-7
pubmed: 14634551
J Gynecol Obstet Biol Reprod (Paris). 2004 Nov;33(7):577-88
pubmed: 15550876
Neurourol Urodyn. 2008;27(8):749-57
pubmed: 18951445
Best Pract Res Clin Obstet Gynaecol. 2015 May;29(4):554-64
pubmed: 25770750
Curr Pain Headache Rep. 2019 Jul 1;23(7):51
pubmed: 31263977
Reprod Health. 2021 Feb 19;18(1):45
pubmed: 33608022
Gynecol Obstet Fertil Senol. 2020 Jun;48(6):475-476
pubmed: 31870836
JSLS. 2002 Apr-Jun;6(2):115-9
pubmed: 12113413
Lancet. 2003 Jun 14;361(9374):2032-5
pubmed: 12814714
Urol Clin North Am. 2001 Feb;28(1):151-7
pubmed: 11277060
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Obstet Gynecol. 2004 Apr;103(4):674-80
pubmed: 15051558
Am J Obstet Gynecol. 2012 Jan;206(1):83.e1-7
pubmed: 21963098
Am J Obstet Gynecol. 2017 Jul;217(1):11-26.e3
pubmed: 28188775
Am J Obstet Gynecol. 2011 Apr;204(4):360.e1-7
pubmed: 21306698
Ann Surg Oncol. 2016 Jul;23(7):2192-8
pubmed: 26744108
JSLS. 2012 Jul-Sep;16(3):421-7
pubmed: 23318068
Hum Reprod. 2009 Dec;24(12):3057-62
pubmed: 19801572
Int J Gynaecol Obstet. 2013 Jan;120(1):49-52
pubmed: 23044008
Int Urogynecol J. 2013 Oct;24(10):1679-86
pubmed: 23563891
Int Urogynecol J. 2018 Jan;29(1):81-89
pubmed: 28894904
Eur Urol. 2003 Dec;44(6):724-30
pubmed: 14644127
Obstet Gynecol. 2004 Oct;104(4):805-23
pubmed: 15458906